Skip to main content

Tafasitamab-cxix

(TA-fuh-SIH-tuh-mab)

This page contains brief information about tafasitamab-cxix and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Monjuvi
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tafasitamab-cxix is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that tafasitamab-cxix provides a clinical benefit in these patients.

Tafasitamab-cxix is also being studied in the treatment of other types of cancer.

More About Tafasitamab-cxix

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Monoclonal Antibodies

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Tafasitamab-cxix - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: